NCT04957836|Completed
Loading search results
Sponsor study identifier
observational
1,216
1 country
1
Study Start
May 21, 2021
Actual (reported)Primary Completion
June 29, 2021
Actual (reported)Study Completion
June 29, 2021
Actual (reported)Postoperative respiratory complications according to the type of drug (sugammadex, pyridostigmine) used for reversible neuromuscular block when extubating an endotracheal tube in the operating room after minimally invasive cardiac surgery, and the length of intensive care unit stay are going to be checked. Through these results, it will be investigated whether the use of rocuronium-sugarmadex for neuromuscular block and reversal in patients undergoing minimally invasive cardiac surgery is clinically useful.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 29, 2021
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 21, 2021
Actual (reported)June 29, 2021
Actual (reported)June 29, 2021
Actual (reported)June 29, 2021
Actual (reported)July 12, 2021
Actual (reported)Postoperative respiratory complications
Postoperative respiratory complications
from time point of extubation in the operating room to time point of transferring patient to general ward (up to 6 months)
the length of intensive care unit stay
during ICU hospitalization (up to 6 months)
reversal with sugammadex for immediate extubation in the operating room
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
In the case of an endotracheal tube extubation in the operating room among adult patients over the age of 18 who underwent minimally invasive cardiac surgery
Pusan National University Yangsan Hospital
Yangsan, South Korea
Hee Young Kim, MD, PhD
Pusan National University Yangsan Hospital
1,216 participants (actual enrollment reported by the registry).
First Submitted
June 29, 2021
First Posted
July 12, 2021
Study Start
May 21, 2021
Actual (reported)Safety and Effectiveness of No-touch Technique for Ascending Aorta in MICS-CABG
Contact the study team to confirm eligibility.
Primary Completion
June 29, 2021
Actual (reported)Study Completion
June 29, 2021
Actual (reported)Last Updated
August 12, 2024
Record last verified: 2024-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: